Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2021 | Future targets for pancreatic cancer treatment

Michael Kim, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the future of treatment for pancreatic cancer, highlighting potential targeting of pathways impacted by mutant p53 or oncogenic KRAS, such as CREB1, to prevent metastasis. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.